Neuroblastoma Origin and Therapeutic Targets for Immunotherapy

por Kholodenko, Irina V., Kalinovsky, Daniel V., Doronin, Igor I., Deyev, Sergey M., Kholodenko, Roman V.
Publicado 2018

Properties of a cryptic lysyl oxidase from haloarchaeon Haloterrigena turkmenica

por Pestov, Nikolay B., Kalinovsky, Daniel V., Larionova, Tatyana D., Zakirova, Alia Z., Modyanov, Nikolai N., Okkelman, Irina A., Korneenko, Tatyana V.
Publicado 2019

Targeting GD2-Positive Tumor Cells by Pegylated scFv Fragment–Drug Conjugates Carrying Maytansinoids DM1 and DM4

por Kalinovsky, Daniel V., Kholodenko, Irina V., Svirshchevskaya, Elena V., Kibardin, Alexey V., Ryazantsev, Dmitry Yu., Rozov, Fedor N., Larin, Sergey S., Deyev, Sergey M., Kholodenko, Roman V.
Publicado 2023

Therapeutic efficacy of antibody-drug conjugates targeting GD2-positive tumors

por Kalinovsky, Daniel V, Kibardin, Alexey V, Kholodenko, Irina V, Svirshchevskaya, Elena V, Doronin, Igor I, Konovalova, Mariya V, Grechikhina, Maria V, Rozov, Fedor N, Larin, Sergey S, Deyev, Sergey M, Kholodenko, Roman V
Publicado 2022

Minibody-Based and scFv-Based Antibody Fragment-Drug Conjugates Selectively Eliminate GD2-Positive Tumor Cells

por Kalinovsky, Daniel V., Kholodenko, Irina V., Kibardin, Alexey V., Doronin, Igor I., Svirshchevskaya, Elena V., Ryazantsev, Dmitriy Y., Konovalova, Maria V., Rozov, Fedor N., Larin, Sergey S., Deyev, Sergey M., Kholodenko, Roman V.
Publicado 2023